Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
FL.1.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.1.6NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GA.4.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GA.4.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GA.4.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GA.4.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GW.5.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GW.5.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GW.5.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
GW.5.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JE.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JE.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JE.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JE.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EG.5.2.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
EG.5.2.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.5.2.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.5.2.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.11ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.11ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.11NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-6672.85US
DV.7.1.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
DV.7.1.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-15341.2China
DV.7.1.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
DV.7.1.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.16.23ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.16.23ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.16.23ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.16.23NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GN.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GN.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GN.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GN.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JH.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JH.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JH.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JH.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GJ.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GJ.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GJ.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GJ.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GJ.1.2.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GJ.1.2.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GJ.1.2.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GJ.1.2.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HN.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HN.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HN.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HN.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used